Skip to content
HelpLine 1-800-298-2436|info@lungcanceralliance.org
  • About Us
  • Research
  • Blog
  • Advocacy
  • For Professionals
  • Donate Today!
Lung Cancer Alliance Logo
  • Home
  • What is Lung Cancer
    • Symptoms
    • Diagnosis
      • Coping with Diagnosis
    • Types of Lung Cancer
    • Stages of Lung Cancer
    • Second Opinions
  • Risk & Early Detection
    • About Screening
      • Frequently Asked Questions
      • Screening Facts & Figures
    • Risk Factors
    • Screening Centers
  • Treatments & Side Effects
    • Molecular Testing
    • Clinical Trials
      • Frequently Asked Questions About Clinical Trials
    • Treatment Options
      • Chemotherapy
      • Radiation
      • Surgery
      • Immunotherapy
        • Checkpoint Inhibitors
        • Vaccines
        • Molecular Tests and Biomarkers
      • Targeted Therapy
        • Drugs Targeting EGFR
        • Drugs Targeting ALK
        • Drugs Targeting ROS1
        • Drugs Targeting BRAF
        • Drugs Targeting NTRK
        • Other Targeted Therapies
      • Clinical Trials
      • Ablation Therapy
      • Complementary and Alternative Medicine
      • Hospice Care
      • Palliative Care
      • Photodynamic Therapy
    • Treatment Centers
    • Side Effect Management
    • Lung Cancer Stigma
    • Staying Healthy
  • Resources & Support
    • Our Services
      • HelpLine & Support
      • Emotional Support
      • LungMATCH: Treatment Guidance
      • Financial and Other Resources
    • Support Groups
    • Educational Materials
      • Glossary
      • Webinars
      • Questions for Your Healthcare Team
  • Get Involved
    • Ways to Give
    • How Your Support Helps
    • Lung Cancer Awareness
    • Share Your Story
    • Start a Fundraiser
    • Events
      • Shine a Light on Lung Cancer
      • Lung Love Run/Walk
      • 2019 National Advocacy Summit
      • Screening & Care Conference
    • Merchandise Store
    • Rays of Hope Award
    • How to Become an Advocate

register

Gabriele Wright2018-10-23T18:30:14+00:00October 23rd, 2018|0 Comments

Share This Story.

FacebookTwitterTumblrPinterestEmail

Leave A Comment Cancel reply

Categories

  • Events
  • Hot Topics
  • News
  • Stories of Hope
  • Uncategorized

Recent Posts

  • FDA Approves Genentech’s Rozlytrek (entrectinib) for ROS1 Non-Small Cell Lung Cancer (NSCLC) and NTRK-Driven Tumors
  • Celebrating Survivorship and Making a Difference
  • Crisis and Relief: Reflections on World Lung Cancer Day
  • GO2 Foundation Presents 2019 Bonnie J. Addario Lectureship Award at ILCC
  • An Update on the Burn Pits Accountability Act of 2019

Archives

Lung Cancer Alliance Donate Today!
  • What is Lung Cancer
  • Symptoms
  • Types of Lung Cancer
  • Diagnosis
  • Stages of Lung Cancer
  • Second Opinions
  • Coping with Diagnosis
  • Risk & Early Detection
  • About Screening
  • Screening Facts & Figures
  • Frequently Asked Questions
  • Risk Factors
  • Screening Centers
  • Treatments & Side Effects
  • Molecular Testing
  • Clinical Trials
  • Treatment Options
  • Treatment Centers
  • Side Effect Management
  • Staying Healthy
  • Resources and Support
  • Questions to Ask Your Doctor
  • Our Services
  • Emotional Support
  • Support Groups
  • Webinars
  • Glossary
  • Educational Materials
  • LungMATCH: Treatment Guidance
  • Get Involved
  • Ways to Give
  • How Your Support Helps
  • Events
© Lung Cancer Alliance. The information presented in this website is not intended as a substitute for medical care. Please talk with your healthcare provider about any information you get from this website.
  • About Us
  • Research
  • Blog
  • Advocacy
  • For Professionals
  • HelpLine: 1-800-298-2436 info@lungcanceralliance.org
  • Facebook
  • Twitter
  • Instagram
  • Youtube